Ret, active

N-terminal GST-tagged recombinant, human Ret amino acids 658-end.

Catalog #: 14-570

$399.00$2,989.00


Inquire
Biological Information
Background Information:
The RET (rearranged during transfection) receptor tyrosine kinase is a classic example of phenotype heterogeneity. Gain-of-function mutations of RET are associated with human cancer and multiple endocrine neoplasia type 2 (MEN 2A, MEN 2B, etc.) Loss-of-function mutations of RET cause Hirschspung disease or colonic aganglionosis). GenBank NM_000323
Target Class:
Kinase
Accession Number:
NM_020630.4; NM_020975.4
Target Name:
Ret
Target Aliases:
RET, HSCR1, MEN2A, PTC, CDHF12, RET51, RET-ELE1, C-ret, MTC1, MEN2B
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
6 months at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Datasheets

14-570x Datasheet

View Document